CNS Pharmaceuticals, Inc.

CNSP

N/A

NASDAQBiotechnology🇺🇸North America4 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Feb 1, 2026

Drug Pipeline

Drug Name	Phase	Indication	Designations
Berubicin	Phase 2	Glioblastoma Multiforme, Adult	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

Feb 1, 2026Berubicin

Primary completion for Berubicin trial (NCT04762069) in Glioblastoma Multiforme, Adult

Regulatory Approvals

CNSP News